by Raynovich Rod | Aug 28, 2019 | Biopharmaceuticals
Update-1 Aug 31 Saturday-Biotech Stocks on the Road to Nowhere? IBB flat for the week at $102.89, down 5 pts for the month. XBI flat for the week at $80.37 down 7 pts for the month. Alexion (ALXN) down 10.17% to $100.76 on patent challenge from Amgen (AMGN) on...
by Raynovich Rod | Aug 19, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update -3 Bearish trends in biopharma continue with both the IBB and XBI down with 30 min of trading to go. We will do a review of the healthcare sector later this week continuing the theme after the AACC of the need for diversification within healthcare e.g. medtech,...
by Raynovich Rod | Aug 12, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update-3…8/16 Big reversal day…summary this weekend with XBI up 2.65% at $82.46 just above support. Update-2… 8/14 Nowhere to hide from Global economic fears-welcome to whipsaw trading. Technicals matter not tweets. Market averages down about 3%...
by Raynovich Rod | Jul 28, 2019 | Biopharmaceuticals
8/5… Risk OFF with Trade War and a Currency War XBI down 3.33% to $81.22, IBB down 2.65% to $102.29. WE will update later this week. Tuesday 8/6 we will attend the AACC Clinical EXPO in Anaheim CA. ======== Update-2..8/1 1:30p VRTX sparks biopharma stocks up 6%...
by Raynovich Rod | Jul 22, 2019 | Biopharmaceuticals, Macro
Update -3 …Nice biotech rally today; green screen in gene therapy and mid-cap sectors. XBI and IWM up over 1%. Update-2…Small cap reversal IWM up 1.67% to $157 level; our small cap portfolio winners: AMRN CFMS GNMK MGTX VCEL etc. but XBI still lags stuck...
by Raynovich Rod | Jul 15, 2019 | Biopharmaceuticals, Macro
Update-2 11:30a EDT Seattle Genetics (SGEN) revenues grow 30% , stock soars 15%.This is the way large cap biotech model is supposed to work-grow top line revenue.The Company is a leader in oncology with antibody-drug conjugates (ADC). ===== Update-1 Biopharma stocks...
by Raynovich Rod | Jul 11, 2019 | Biopharmaceuticals
Update-1 11a EDT, Large cap drugs and biotechs resume slide on drug pricing “reform” from Trump threats. IBB down 1.37%, XPH in downtrend tp $38.41. Laggards holding BIB, GILD. Winners losing MRK, RHHBY. LLY and PFE hit hard. Gene therapy green: BOLD,SGMO....
by Raynovich Rod | Jun 30, 2019 | Biopharmaceuticals
Update-1 A bit of a sell-off in gene therapy but MGTX at new highs at $29.44. Profit taking on Sarepta down 3.84% to $150.59. Roche (RHHBY) and Merck (MRK) near new highs. Mid-caps mixed but Novacure (NVCR) rally 3.27% toward new highs. One of our top picks Amarin...
by Raynovich Rod | Jun 27, 2019 | Biopharmaceuticals, Macro
Crazy Stealth Biotech Rally in Small Caps-Who Gave the Buy Signal? NASDAQ up 0.73%, XLV up 0.70 %. MedTech and Dx/Tools also green. IWM up 1.88% to $153.63 up 14% YTD, lagging XBI up 20.7% YTD. Volatile market for traders in small caps. It was a green screen for small...
